Skip to content

Validation of a Questionnaire Assessing Quality of Life in Children With Amblyopia and Strabismus

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02880488
Acronym
ASTEQ
Enrollment
294
Registered
2016-08-26
Start date
Unknown
Completion date
Unknown
Last updated
2016-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Amblyopia, Strabismus

Brief summary

The validation of a French questionnaire is very important to assess rigorously and objectively the impact of the treatments of strabismus and amblyopia on children quality of life.

Interventions

None listed

Sponsors

Fondation Ophtalmologique Adolphe de Rothschild
Lead SponsorNETWORK

Study design

Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
3 Years to 17 Years

Inclusion criteria

* children with a status of strabismus or not strabismus made by a specialized ophthalmologist * children with a status of amblyopia or not amblyopia made by a specialized ophthalmologist * signed consent of parents

Exclusion criteria

* ocular pathology (except for isolated ametropia) * evolutive paralytic strabismus * antecedent of surgery for strabismus * strabismus surgery in the past 6 months * disease with possible impact on the child's answers, such as severe neurologic troubles) * poor knowledge of French language

Design outcomes

Primary

MeasureTime frame
validation of the questionnaireimmediate

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026